Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma

PHASE3CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

December 31, 1994

Primary Completion Date

September 30, 2000

Study Completion Date

September 30, 2006

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

cytarabine

DRUG

doxorubicin hydrochloride

DRUG

leucovorin calcium

DRUG

mercaptopurine

DRUG

methotrexate

DRUG

prednisone

DRUG

vincristine sulfate

RADIATION

low-LET cobalt-60 gamma ray therapy

RADIATION

low-LET electron therapy

RADIATION

low-LET photon therapy

Trial Locations (10)

1211

Clinique de Pediatrie, Geneva

22908

Cancer Center, University of Virginia HSC, Charlottesville

28801

Memorial Mission Hospital, Asheville

67214

Via Christi Regional Medical Center-Saint Francis Campus, Wichita

70112

MBCCOP - LSU Medical Center, New Orleans

75230

Medical City Dallas Hospital, Dallas

78284

University of Texas Health Science Center at San Antonio, San Antonio

29425-0721

Medical University of South Carolina, Charleston

78236-5300

San Antonio Military Pediatric Cancer and Blood Disorders Center, Lackland Air Force Base

00936-5067

University of Puerto Rico School of Medicine Medical Sciences Campus, San Juan

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00002618 - Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma | Biotech Hunter | Biotech Hunter